Ricardo Sein Najera in San Juan, Puerto Rico

Home Puerto Rico San Juan

Ricardo Sein Najera has Nuclear Medicine as his primary medical specialty. Their primary office is: 126 Ave De Diego in San Juan, Puerto Rico. There are 2 additional office locations for Ricardo Sein Najera that can be viewed towards the end of their profile. They attended Sorry, his university is not listed and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ricardo J Sein Najera Office Phone and Directions

Ricardo Sein Najera
126 Ave De Diego
San Juan, Puerto Rico 00936
787-622-7333

Patient Ratings
Please rate your experience with Ricardo Sein Najera below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 787-622-7333

Enter a starting address:

Healthcare Info for Ricardo Sein Najera

Medical School: Sorry, his university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Ricardo Sein Najera is listed as: Nuclear Medicine
Approximate Years of Experience: 21
PAC (PECOS ID)#: 1254599475
NPI #: 1376744615
NPI Created On: 05/31/2007
NPI Last Updated Listed as: 06/03/2011
Primary Taxonomy Code: 207UN0902X

URL not found for state: PR licensing board.
License Number:
18141
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Bone and/or joint imaging, whole body
Bone and/or joint imaging, 3 phase study
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
Technetium tc-99m sestamibi, diagnostic, per study dose
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries
Injection, aminophyllin, up to 250 mg
Injection, regadenoson, 0.1 mg